Clinical Trial: A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma

U.S., April 14 -- ClinicalTrials.gov registry received information related to the study (NCT07522073) titled 'A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma' on April 03.

Brief Summary: The purpose of this study is to evaluate the efficacy and safety of standard chemotherapy with or without INCB161734 in participants with metastatic pancreatic ductal adenocarcinoma (PDAC).

Study Start Date: April 09

Study Type: INTERVENTIONAL

Condition: Solid Tumors

Intervention: DRUG: INCB161734

Oral; tablet

DRUG: Placebo

Oral; tablet

DRUG: Investigator's choice of chemotherapy

The investigator will select the chemotherapy in accordance with the ...